BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28199989)

  • 41. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.
    Carpagnano GE; Foschino-Barbaro MP; Spanevello A; Resta O; Carpagnano F; Mulé G; Pinto R; Tommasi S; Paradiso A
    Am J Respir Crit Care Med; 2008 Feb; 177(3):337-41. PubMed ID: 17962633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of cytokine pattern in exhaled breath condensate of patients with squamous cell lung carcinoma.
    Barta I; Kullmann T; Csiszer E; Antus B
    Int J Biol Markers; 2010; 25(1):52-6. PubMed ID: 20155714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exhaled breath condensate pH decreases during exercise-induced bronchoconstriction.
    Bikov A; Galffy G; Tamasi L; Bartusek D; Antus B; Losonczy G; Horvath I
    Respirology; 2014 May; 19(4):563-9. PubMed ID: 24612285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of the clinical application of detecting EGFR, KRAS, PIK3CA and BRAF mutations in patients with non-small cell lung cancer using next-generation sequencing.
    Xu X; Yang Y; Li H; Chen Z; Jiang G; Fei K
    Scand J Clin Lab Invest; 2016 Sep; 76(5):386-92. PubMed ID: 27215271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases.
    Carpagnano GE; Lacedonia D; Carone M; Soccio P; Cotugno G; Palmiotti GA; Scioscia G; Foschino Barbaro MP
    J Breath Res; 2016 Apr; 10(2):026005. PubMed ID: 27063576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients.
    Malapelle U; Vigliar E; Sgariglia R; Bellevicine C; Colarossi L; Vitale D; Pallante P; Troncone G
    J Clin Pathol; 2015 Jan; 68(1):64-8. PubMed ID: 25378536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. pH in nasal exhaled breath condensate in healthy adults.
    Svensson S; Hellgren J
    Rhinology; 2007 Sep; 45(3):214-7. PubMed ID: 17956021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report.
    Valtcheva N; Lang FM; Noske A; Samartzis EP; Schmidt AM; Bellini E; Fink D; Moch H; Rechsteiner M; Dedes KJ; Wild PJ
    BMC Cancer; 2017 Jan; 17(1):66. PubMed ID: 28103826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Ambient and Atmospheric Pressure Ion Sources for Cystic Fibrosis Exhaled Breath Condensate Ion Mobility-Mass Spectrometry Metabolomics.
    Zang X; Pérez JJ; Jones CM; Monge ME; McCarty NA; Stecenko AA; Fernández FM
    J Am Soc Mass Spectrom; 2017 Aug; 28(8):1489-1496. PubMed ID: 28364225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The gene mutational discrepancies between primary and paired metastatic colorectal carcinoma detected by next-generation sequencing.
    Zou SM; Li WH; Wang WM; Li WB; Shi SS; Ying JM; Lyu N
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2149-2159. PubMed ID: 30171333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concentration of exhaled breath condensate biomarkers after fractionated collection based on exhaled CO2 signal.
    Goldoni M; Corradi M; Mozzoni P; Folesani G; Alinovi R; Pinelli S; Andreoli R; Pigini D; Tillo R; Filetti A; Garavelli C; Mutti A
    J Breath Res; 2013 Mar; 7(1):017101. PubMed ID: 23445573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach.
    Fiorentino M; Gruppioni E; Massari F; Giunchi F; Altimari A; Ciccarese C; Bimbatti D; Scarpa A; Iacovelli R; Porta C; Virinder S; Tortora G; Artibani W; Schiavina R; Ardizzoni A; Brunelli M; Knuutila S; Martignoni G
    Oncotarget; 2017 Jan; 8(5):7328-7335. PubMed ID: 27741505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing.
    Liu S; Wang H; Zhang L; Tang C; Jones L; Ye H; Ban L; Wang A; Liu Z; Lou F; Zhang D; Sun H; Dong H; Zhang G; Dong Z; Guo B; Yan H; Yan C; Wang L; Su Z; Li Y; Huang XF; Chen SY; Zhou T
    Hum Genomics; 2015 Feb; 9(1):2. PubMed ID: 25757876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer.
    Carpagnano GE; Foschino-Barbaro MP; Mulé G; Resta O; Tommasi S; Mangia A; Carpagnano F; Stea G; Susca A; Di Gioia G; De Lena M; Paradiso A
    Am J Respir Crit Care Med; 2005 Sep; 172(6):738-44. PubMed ID: 15947287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer.
    Jing C; Mao X; Wang Z; Sun K; Ma R; Wu J; Cao H
    Mol Med Rep; 2018 Aug; 18(2):2191-2197. PubMed ID: 29956783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits.
    Ma W; Brodie S; Agersborg S; Funari VA; Albitar M
    Mol Diagn Ther; 2017 Oct; 21(5):571-579. PubMed ID: 28639239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
    de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
    PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.
    De Luca C; Rappa AG; Gragnano G; Malapelle U; Troncone G; Barberis M
    J Clin Pathol; 2018 Aug; 71(8):745-750. PubMed ID: 29798838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry.
    Nummela P; Saarinen L; Thiel A; Järvinen P; Lehtonen R; Lepistö A; Järvinen H; Aaltonen LA; Hautaniemi S; Ristimäki A
    Int J Cancer; 2015 Mar; 136(5):E282-9. PubMed ID: 25274248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
    Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
    Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.